By Nigam Arora & Dr. Natasha Arora
Long term investments are great, but there is an advantage to doing at least some short term trades to accelerate wealth generation.
Please click here for a chart of Snap (SNAP).
The chart shows Arora Buy Signal was given at $28.20 right after SNAP reported earnings. The reason behind the buy signal was that SNAP earnings were better than the consensus. SNAP reported earnings right after earnings from Meta Platform (FB), previously known as Facebook. Facebook reported earnings less than the consensus, and Facebook stock was crushed.
Both Snap and Facebook are social media stocks. After Facebook earnings, there was a lot of selling in SNAP stock.
The Arora Report typically gives a stop zone simultaneously with the buy signal. The purpose of the stop zone is to control risk.
The chart shows Arora Sell Signal was given at $38.22.
The chart shows that the trade produced 36% gain in 45 minutes.
Would you like to take advantage of opportunities that make 36% in 45 minutes? We invite you to take a 30 day free trial.
Please click here to take advantage of the 30 day free trial.
Markets can generate substantial wealth for knowledgeable investors. NOW YOU TOO CAN ALSO SPECTACULARLY SUCCEED AT MEETING YOUR GOALS WITH THE HELP OF THE ARORA REPORT. You are receiving less than 2% of the content from our paid services. …TO RECEIVE REMAINING 98% INCLUDING MANY ATTRACTIVE INVESTMENT OPPORTUNITIES, TAKE A FREE TRIAL TO PAID SERVICES.
Please click here to take advantage of a FREE 30 day trial.
Nigam Arora
Nigam Arora is known for his accurate stock market calls. Nigam is a distinguished master of the macro. He is a popular columnist with over 100 million page views, an engineer, and nuclear physicist by background. Nigam has founded two Inc. 500 fastest growing companies and has been involved in over 50 entrepreneurial ventures. He is the developer of Theory ZYX of Successful Change Management and is the author of the book on Theory ZYX, as well as the developer of the ZYX Change Method for Investing.
Dr. Natasha Arora
Dr. Natasha Arora has significant expertise in investment analysis especially biotech, healthcare, and technology. Natasha is a graduate of Harvard Medical School followed by a postdoc at MIT. She has published several peer reviewed research papers in top science journals.
